During ultrasonic treatment, cavitation produces physical forces in the surrounding fluid that disturb material attached to the removed implant. These forces can disrupt biofilms, which may otherwise retain bacteria or fungi on the surface, and release the organisms into the fluid. Testing that fluid therefore provides access to microorganisms that might not be recovered efficiently from the implant itself.
Biofilm-associated microorganisms can remain attached to an implant surface, making them difficult to detect through conventional tissue sampling alone. Sonication fluid analysis targets this surface-associated population by transferring released bacteria or fungi into a testable fluid. This distinction matters because identifying organisms linked to the implant can strengthen the microbiological assessment of a suspected infection.
Conventional tissue samples examine microorganisms recovered from surrounding tissue, whereas sonication fluid analysis examines organisms released from the removed implant surface. The two approaches access different microbial locations. Because sonication can disrupt surface biofilms, it may reveal bacteria or fungi that are difficult to recover from tissue samples, providing complementary information during evaluation of implant-associated infection.
The process begins after a medical implant has been removed and fluid has been collected following ultrasonic treatment. The resulting sonication fluid is then subjected to microbiological evaluation, using culture, molecular testing, or both. This workflow converts microorganisms detached from the implant surface into a sample that can be analyzed for evidence of infection.
Sonication fluid can undergo culture or molecular testing to investigate microorganisms released from the implant. Culture supports recovery of bacteria or fungi in the fluid, while molecular testing examines microbial material through a different analytical route. Using these options allows the sample to provide microbiological evidence that may help characterize an implant-associated infection.
The method is particularly relevant when clinicians evaluate suspected infections involving removed implants, including orthopedic prostheses. Its findings can help detect biofilm-associated bacteria or fungi, support diagnosis, and guide antimicrobial selection. By clarifying which microorganisms are associated with the implant, the results may also contribute to broader clinical management decisions.